Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Comparing pneumococcal conjugate vaccine schedules in infancy.

Low N, Scott P, Henao Restrepo AM.

Vaccine. 2012 Nov 26;30(50):7145. doi: 10.1016/j.vaccine.2012.01.019. Epub 2012 Feb 10. No abstract available.

PMID:
22326900
2.

Immunogenicity and reactogenicity of a 13-valent-pneumococcal conjugate vaccine administered at 2, 4, and 12 months of age: a double-blind randomized active-controlled trial.

Snape MD, Klinger CL, Daniels ED, John TM, Layton H, Rollinson L, Pestridge S, Dymond S, Galiza E, Tansey S, Scott DA, Baker SA, Jones TR, Yu LM, Gruber WC, Emini EA, Faust SN, Finn A, Heath PT, Pollard AJ.

Pediatr Infect Dis J. 2010 Dec;29(12):e80-90.

PMID:
21155091
3.

Comparing pneumococcal conjugate vaccine schedules based on 3 and 2 primary doses: systematic review and meta-analysis.

Scott P, Rutjes AW, Bermetz L, Robert N, Scott S, Lourenço T, Egger M, Low N.

Vaccine. 2011 Dec 6;29(52):9711-21. doi: 10.1016/j.vaccine.2011.07.042. Epub 2011 Aug 5. Review.

PMID:
21821080
4.

Immunogenicity of pneumococcal conjugate vaccines in infants after two or three primary vaccinations: a systematic review and meta-analysis.

Rückinger S, Dagan R, Albers L, Schönberger K, von Kries R.

Vaccine. 2011 Dec 6;29(52):9600-6. doi: 10.1016/j.vaccine.2011.09.011. Epub 2011 Sep 18. Review.

PMID:
21933696
5.

A randomized study comparing combined pneumococcal conjugate and polysaccharide vaccination schedules in adults.

Lazarus R, Clutterbuck E, Yu LM, Bowman J, Bateman EA, Diggle L, Angus B, Peto TE, Beverley PC, Mant D, Pollard AJ.

Clin Infect Dis. 2011 Mar 15;52(6):736-42. doi: 10.1093/cid/cir003.

PMID:
21367726
6.

Advances in pneumococcal disease prevention: 13-valent pneumococcal conjugate vaccine for infants and children.

Paradiso PR.

Clin Infect Dis. 2011 May;52(10):1241-7. doi: 10.1093/cid/cir142. Review.

PMID:
21507921
7.

Indirect effect of conjugate pneumococcal vaccination in a 2+1 dose schedule.

Vestrheim DF, Høiby EA, Bergsaker MR, Rønning K, Aaberge IS, Caugant DA.

Vaccine. 2010 Mar 2;28(10):2214-21. doi: 10.1016/j.vaccine.2009.12.054. Epub 2010 Jan 5.

PMID:
20056192
8.

Immunization of preterm infants with 10-valent pneumococcal conjugate vaccine.

Omeñaca F, Merino JM, Tejedor JC, Constantopoulos A, Papaevangelou V, Kafetzis D, Tsirka A, Athanassiadou F, Anagnostakou M, François N, Borys D, Schuerman L.

Pediatrics. 2011 Aug;128(2):e290-8. doi: 10.1542/peds.2010-1184. Epub 2011 Jul 4.

PMID:
21727108
9.

Immunogenicity of 10-valent pneumococcal nontypeable Haemophilus Influenzae Protein D Conjugate Vaccine when administered as catch-up vaccination to children 7 months to 5 years of age.

Vesikari T, Karvonen A, Korhonen T, Karppa T, Sadeharju K, Fanic A, Dieussaert I, Schuerman L.

Pediatr Infect Dis J. 2011 Aug;30(8):e130-41. doi: 10.1097/INF.0b013e31821d1790.

PMID:
21540760
10.

Safety and immunogenicity of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Chilean children.

Lagos RE, Muñoz AE, Levine MM, Lepetic A, François N, Yarzabal JP, Schuerman L.

Hum Vaccin. 2011 May;7(5):511-22. Epub 2011 May 1.

PMID:
21441782
11.

Lack of pneumococcal antigenuria in infants immunized with heptavalent pneumococcal conjugate vaccine.

Hilal K, Carey R, Challapalli M.

Pediatr Infect Dis J. 2001 Sep;20(9):912.

PMID:
11734775
12.

Immunogenicity and safety of heptavalent conjugate vaccine against Streptococcus pneumoniae in pre-term Polish infants.

Szynczewska E, Chlebna-Sokół D.

Vaccine. 2011 Sep 16;29(40):7107-13. doi: 10.1016/j.vaccine.2011.06.124. Epub 2011 Jul 29.

PMID:
21803093
13.
14.

Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine (PCV13) when given as a toddler dose to children immunized with PCV7 as infants.

Grimprel E, Laudat F, Patterson S, Baker SA, Sidhu MS, Gruber WC, Emini EA, Scott DA.

Vaccine. 2011 Dec 6;29(52):9675-83. doi: 10.1016/j.vaccine.2011.10.012. Epub 2011 Oct 18.

PMID:
22008822
15.

Pneumococcal vaccination and revaccination in the elderly population.

Nichol KL.

J Infect Dis. 2010 Mar;201(5):659-61. doi: 10.1086/651376. No abstract available.

PMID:
20113178
16.

Impact of the 10-valent pneumococcal non-typeable Haemophilus influenzae Protein D conjugate vaccine (PHiD-CV) on bacterial nasopharyngeal carriage.

Prymula R, Hanovcova I, Splino M, Kriz P, Motlova J, Lebedova V, Lommel P, Kaliskova E, Pascal T, Borys D, Schuerman L.

Vaccine. 2011 Feb 24;29(10):1959-67. doi: 10.1016/j.vaccine.2010.12.086. Epub 2011 Jan 6.

PMID:
21215830
17.

Resistance of young mice to pneumococcal infection can be improved by oral vaccination with recombinant Lactococcus lactis.

Villena J, Medina M, Racedo S, Alvarez S.

J Microbiol Immunol Infect. 2010 Feb;43(1):1-10. doi: 10.1016/S1684-1182(10)60001-1. Epub 2010 Mar 29.

18.

Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway.

Vestrheim DF, Løvoll O, Aaberge IS, Caugant DA, Høiby EA, Bakke H, Bergsaker MR.

Vaccine. 2008 Jun 19;26(26):3277-81. doi: 10.1016/j.vaccine.2008.03.087. Epub 2008 Apr 18.

PMID:
18456376
19.

Experience with pneumococcal conjugate vaccine in Norway.

Aaberge IS.

Expert Rev Vaccines. 2009 Feb;8(2):159-65. doi: 10.1586/14760584.8.2.159. Review.

PMID:
19196196
20.

Safety, immunogenicity and kinetics of immune response to 7-valent pneumococcal conjugate vaccine in children with idiopathic nephrotic syndrome.

Liakou CD, Askiti V, Mitsioni A, Stefanidis CJ, Theodoridou MC, Spoulou VI.

Vaccine. 2011 Sep 16;29(40):6834-7. doi: 10.1016/j.vaccine.2011.07.053. Epub 2011 Jul 29.

PMID:
21803106

Supplemental Content

Support Center